The results demonstrated that KLF9 silencing reversed the p-PI3K, p-AKT, and p-mTOR expression levels in HCC cells, suggesting that FABP5 regulates the PI3K/AKT signaling pathway by inhibiting KLF9 expression. The gene discussed is KLF9; the disease is hepatocellular carcinoma.